Document is current
Any future updates will be listed below
-
Authors
Bates, Timothy A.
Gurmessa, Sintayehu K.
Weinstein, Jules B.
Trank-Greene, Mila
Wrynla, Xammy Huu
Anastas, Aidan
Anley, Teketay Wassie
Hinchliff, Audrey
Shinde, Ujwal
Burke, John E. https://orcid.org/0000-0001-7904-9859
Tafesse, Fikadu G. https://orcid.org/0000-0002-8575-4164
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AI141549, S10OD023413)
OHSU Silver Innovation Award
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (5T32HL083808)
Gouvernement du Canada | Canadian Institutes of Health Research (168998)
Michael Smith Foundation for Health Research (17686)
- License Information
-
More Information
Article History
Received: 12 December 2023
Accepted: 24 September 2024
First Online: 21 November 2024
Competing interests
: J.E.B. reports personal fees from Scorpion Therapeutics, Reactive therapeutics and Olema Oncology, and research grants from Novartis. All other authors declare no competing interests.
